NCT00002572View on ClinicalTrials.gov

Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 1994

Primary Completion Date

December 31, 1999

Study Completion Date

December 31, 1999

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

muromonab-CD3

BIOLOGICAL

therapeutic tumor infiltrating lymphocytes

PROCEDURE

conventional surgery

Trial Locations (3)

80218

Children's Health Center, Denver

80220

Veterans Affairs Medical Center - Denver, Denver

80262

University of Colorado Cancer Center, Denver

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER